✉news TechnologyTechnology first seen 15 h ago, last 7 h ago, peak #1
AI in Clinical Trials Held Back by Regulatory Gaps
Original: AI Adoption in Clinical Trials Slowed by Regulatory Gaps, Not Technology Limits
Industry commentary says AI adoption in clinical trials is being slowed primarily by unclear and incomplete regulation rather than technological limitations. The argument is that the tools already work well enough, but sponsors and researchers lack clear guidance from regulators on validation, data use and accountability. The discussion is drawing attention among clinical research professionals weighing how quickly to deploy AI in trial design and operations.
Why now: Debate over how regulators should handle AI in drug development is intensifying as adoption grows.
clinical trial industryAIdrug regulators
Rank over time, top of the chart is #1. 4 snapshots from 11 h ago to 7 h ago.
Evidence
- AI Adoption in Clinical Trials Slowed by Regulatory Gaps, Not Technology Limits · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/3842433